首页> 外文期刊>Journal of assisted reproduction and genetics >Does the presence of AGG interruptions within the CGG repeat tract have a protective effect on the fertility phenotype of female FMR1 premutation carriers?
【24h】

Does the presence of AGG interruptions within the CGG repeat tract have a protective effect on the fertility phenotype of female FMR1 premutation carriers?

机译:CGG重复的agg中断是否存在对女性FMR1清除载体的生育表型具有保护作用?

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose While FMR1 premutation carriers (CGG 55-200) were shown to have reduced success with IVF treatment (lower oocyte yield), studies reporting on the association between the number of CGG repeats and patients' response to controlled ovarian hyperstimulation (COH) are inconsistent. In the present study, we aim to explore whether the number of CGG repeats in women with premutation in FMR1 gene, undergoing COH for IVF, correlates with COH variables and whether the number of AGG interruptions may function as a "protective factor" by improving the ovarian response to COH. Methods Retrospective study, in an academic IVF-PGD unit. Fifty-seven consecutive FMR1 premutation carriers who underwent 285 IVF treatment cycles were included. The numbers of CGG repeats and AGG interruptions were retrieved and correlated to the demographics and COH variables. Results There were no significant association between the numbers of CGG or the AGG interruptions and the number of oocyte retrieved or the peak estradiol levels. The lack of association was also observed when including all the IVF treatment cycles or only the first or last IVF treatment cycle. Moreover, no associations were found between the number of CGG repeats or AGG interruptions and other COH variables, i.e., duration of stimulation, the total dose of gonadotropin used, or the number of top-quality embryos. Conclusions No associations were observed between the number of CGG repeats or AGG interruptions and any of the COH variables. Further studies are required to identify early biomarkers of POI to empower FMR1 premutation carriers with risk assessment tools to consider procedures such as fertility preservation.
机译:目的虽然FMR1热情载体(CGG 55-200)随着IVF治疗(较低的卵母细胞产量)减少了成功,但研究CGG重复和患者对受控卵巢过度训练(COH)的响应之间的关联的研究报告是不一致的。在本研究中,我们的目标是探讨在FMR1基因中具有放线的女性的CGG重复的CGG重复的CGG的数量是否与IVF的COH相关,与COH变量相关,并且AGG中断的数量是否可以通过改善来作为“保护因子”。卵巢反应COH。方法回顾性研究,在学术IVF-PGD单位。连续五十七个连续FMR1采用285个IVF治疗周期的热销载体。检索CGG重复和AGG中断的数量与人口统计数据和COH变量相关。结果CGG或AGG中断的数量与检索卵母细胞的数量或峰雌二醇水平之间没有显着关联。当包括所有IVF治疗循环或仅在第一个或最后IVF治疗周期时,还观察到缺乏关联。此外,在CGG重复或AGG中断的数量和其他COH变量之间没有发现关联,即刺激持续时间,使用的促性腺激素的总剂量,或高质量胚胎的数量。结论在CGG重复或AGG中断的数量和任何COH变量之间没有观察到关联。需要进一步的研究来识别POI的早期生物标志物,以授权具有风险评估工具的FMR1热销载体,以考虑生育保存等程序。

著录项

  • 来源
  • 作者单位

    Chaim Sheba Med Ctr Tel Hashomer Infertil &

    IVF Unit Dept Obstet &

    Gynecol Ramat Gan Israel;

    Chaim Sheba Med Ctr Tel Hashomer Infertil &

    IVF Unit Dept Obstet &

    Gynecol Ramat Gan Israel;

    Chaim Sheba Med Ctr Tel Hashomer Infertil &

    IVF Unit Dept Obstet &

    Gynecol Ramat Gan Israel;

    Chaim Sheba Med Ctr Tel Hashomer Infertil &

    IVF Unit Dept Obstet &

    Gynecol Ramat Gan Israel;

    Chaim Sheba Med Ctr Tel Hashomer Infertil &

    IVF Unit Dept Obstet &

    Gynecol Ramat Gan Israel;

    Chaim Sheba Med Ctr Tel Hashomer Infertil &

    IVF Unit Dept Obstet &

    Gynecol Ramat Gan Israel;

    Chaim Sheba Med Ctr Tel Hashomer Infertil &

    IVF Unit Dept Obstet &

    Gynecol Ramat Gan Israel;

    Chaim Sheba Med Ctr Tel Hashomer Infertil &

    IVF Unit Dept Obstet &

    Gynecol Ramat Gan Israel;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医学遗传学;
  • 关键词

    Fragile X syndrome; POI; COH; CGG; AGG; IVF;

    机译:脆弱的X综合征;然后;COH;CGG;AGG;IVF;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号